Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127192341 | 12719234 | 1 | I | 20160825 | 20160907 | 20160907 | EXP | CN-TAKEDA-2016MPI007743 | TAKEDA | WANG Y, DENG S, WU T, XU Y, ZOU D, WANG Y, ET AL.. OUTCOME OF BORTEZOMIB PLUS CHEMOTHERAPY WITH OR WITHOUT STEM CELL TRANSPLANTATION FOR TREATMENT OF MULTIPLE MYELOMA.. CHIN J HEMATOL. 2008;29 (6):397-400 | 0.00 | A | Y | 0.00000 | 20160906 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127192341 | 12719234 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Unknown | 1.3 MG/M2, UNK | 21602 | 1.3 | MG/M**2 | INJECTION | |||||||
| 127192341 | 12719234 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | 0 | ||||||||||
| 127192341 | 12719234 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | 0 | ||||||||||
| 127192341 | 12719234 | 4 | SS | THALIDOMIDE | THALIDOMIDE | 1 | Unknown | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 127192341 | 12719234 | 5 | SS | BLEOMYCIN | BLEOMYCIN SULFATE | 1 | Unknown | 10 MG/M2, UNK | 0 | 10 | MG/M**2 | ||||||||
| 127192341 | 12719234 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 127192341 | 12719234 | 7 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | 40 MG/M2, UNK | 0 | 40 | MG/M**2 | ||||||||
| 127192341 | 12719234 | 8 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | 40 MG/M2, UNK | 0 | 40 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127192341 | 12719234 | 1 | Plasma cell myeloma |
| 127192341 | 12719234 | 2 | Plasma cell myeloma |
| 127192341 | 12719234 | 4 | Plasma cell myeloma |
| 127192341 | 12719234 | 5 | Plasma cell myeloma |
| 127192341 | 12719234 | 6 | Plasma cell myeloma |
| 127192341 | 12719234 | 7 | Plasma cell myeloma |
| 127192341 | 12719234 | 8 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127192341 | 12719234 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127192341 | 12719234 | Acute kidney injury | |
| 127192341 | 12719234 | Blood glucose increased | |
| 127192341 | 12719234 | Constipation | |
| 127192341 | 12719234 | Diarrhoea | |
| 127192341 | 12719234 | Fatigue | |
| 127192341 | 12719234 | Haemoglobin decreased | |
| 127192341 | 12719234 | Lipids increased | |
| 127192341 | 12719234 | Musculoskeletal pain | |
| 127192341 | 12719234 | Nausea | |
| 127192341 | 12719234 | Neuropathy peripheral | |
| 127192341 | 12719234 | Oedema | |
| 127192341 | 12719234 | Platelet count decreased | |
| 127192341 | 12719234 | Pyrexia | |
| 127192341 | 12719234 | Rash | |
| 127192341 | 12719234 | Sinus bradycardia | |
| 127192341 | 12719234 | Tumour lysis syndrome | |
| 127192341 | 12719234 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |